Epigenomics AG (XTER:ECX)
€ 0.7 -0.088 (-11.17%) Market Cap: 490,000.00 Enterprise Value: -2.74 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 45/100

Full Year 2018 Epigenomics AG Earnings Call Transcript

Mar 27, 2019 / 01:30PM GMT
Release Date Price: €268.8 (+0.69%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Epigenomics AG conference call regarding the full year results 2018. (Operator Instructions) Let me now turn the floor over to your host, Mr. Frederic Hilke.

Frederic Hilke
Epigenomics AG - IR Officer

Thanks you very much, Sandra. Hello, and welcome to the conference call on the occasion of the 2018 full year financial results. My name is Frederic Hilke, I am the Investor Relations Manager at Epigenomics since the beginning of the year. With me here on the phone is the CEO of Epigenomics AG, Greg Hamilton. Before I hand over to him for the presentation, let me point out some of the usual legal information. The following presentation will contain expressly or implicitly certain forward-looking statements concerning Epigenomics AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Epigenomics AG to be materially different from any future results, performance or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot